Literature DB >> 18982212

Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives.

Carlos Eduardo Galvão Barboza1, Carlos Viana Poyares Jardim, André Luís Dressler Hovnanian, Bruno Arantes Dias, Rogério Souza.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. Surgical biopsy was usually required for diagnostic confirmation. However, the morbidity, mortality and limited benefit of this procedure have generated discussion regarding noninvasive diagnostic techniques. We present the case of a female patient with progressive dyspnea, hypoxemia and pulmonary hypertension, the last diagnosed via catheterization. Computed tomography revealed septal thickening and diffuse micronodules. Bronchoalveolar lavage revealed occult alveolar hemorrhage. Treatment with an endothelin antagonist was started, resulting in symptomatic and functional improvement. Occult alveolar hemorrhage differentiates PVOD from idiopathic pulmonary hypertension. We believe that this finding, in combination with characteristic tomographic findings, is sufficient to establish a diagnosis of PVOD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982212     DOI: 10.1590/s1806-37132008000900015

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  3 in total

1.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

2.  Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.

Authors:  Heidi Lederer; Bettina Muggli; Rudolf Speich; Ula Treder; Hans Stricker; Jeroen Goede; Silvia Ulrich; Simon F Stämpfli; Alexander Breitenstein
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?

Authors:  Qin Luo; Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Changming Xiong; Zhihong Liu
Journal:  BMC Pulm Med       Date:  2019-12-19       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.